In the News
powered by Ovast-
FDA Issues Multiple Sclerosis Drug Alert
reshealth.org 2 weeks agoHeart risks spur warning about Gilenya
-
FDA Panel Votes Against New Use For Blood Thinner Xarelto
yahoo.com 4 days, 21 hours agoWEDNESDAY, May 23 (HealthDay News) -- An advisory panel to the U.S. Food and Drug Administration on Wednesday voted against a new use of a new blood thinner, Xarelto, to cut the risk of potentially lethal clots in people with acute coronary syndrome.


Loading More Stories